PUBLIC COMPANY
save$VTRSViatris Inc
$VTRS16.12-0.77%Canonsburg, PA, USupdated 8h ago
Viatris Inc. is an American global pharmaceutical and healthcare corporation headquartered in Canonsburg, Pennsylvania. The corporation was formed through the merger of Mylan and Upjohn, a legacy division of Pfizer, on November 16, 2020.
community read0 votes
🐶 often sniffed alongside
top 8- tagRecall13 co-mentions · 13 sources
- druglevothyroxine sodium11 co-mentions · 11 sources
- drugEuthyrox11 co-mentions · 11 sources
- drugTirosint11 co-mentions · 11 sources
- drugLevolet11 co-mentions · 11 sources
- drugErmeza11 co-mentions · 11 sources
- drugLevoxyl11 co-mentions · 11 sources
- companyMylan Pharmaceuticals Inc11 co-mentions · 11 sources
pipeline
23
marketed
16
phase 3
2
catalysts ytd
12
approvals ytd
6
recalls ytd
3
Pipeline(23)
view full pipeline →pipeline depth23 products
1Preclinical2Phase 316Marketed3pre_registration1Unknown
Marketed
Cardura
Storage Symptoms of Benign Prostatic Hyperplasia
MarketedDetrol LA
Overactive Bladder
MarketedDilantin
Partial Seizure
MarketedEffexor XR
Depression
MarketedErmeza
Hypothyroidism
MarketedGeodon
Bipolar Disorder (Manic Depression)
MarketedInspra
Congestive Heart Failure (Heart Failure)
MarketedLipitor
Cardiovascular Risk Factors
MarketedLyrica
Partial Seizure
MarketedNeurontin
Postherpetic Neuralgia
MarketedNitrostat
Angina (Angina Pectoris)
MarketedRelpax
Migraine
Upcoming
Recent(90d)
view all catalysts →Active trials
- phase4Dymista in Chinese Adolescents
- —Safety and Efficacy Evaluation of <Dovprela Tablets 200 mg> by Post-marketing Surveillance
- phase1A Bioequivalence Study of Sacubitril/Valsartan Film-coated Tablets Under Fasting Conditions
- phase1A Bioequivalence Study of Sacubitril/Valsartan Film-coated Tablets Under Fasting Conditions
Insider activity
source: SEC Form 4open-market buys + sells
- Mar 23, 26SELLCampbell Paul· See Remarks−$284K↗
routine RSU / option mechanics (6)
- Apr 15, 26tax coverLe Goff Corinne · Chief Commercial Officer17,450 sh
- Apr 15, 26tax coverLe Goff Corinne · Chief Commercial Officer1,617 sh
- Apr 15, 26option exerciseLe Goff Corinne · Chief Commercial Officer3,644 sh
- Apr 15, 26option exerciseLe Goff Corinne · Chief Commercial Officer39,344 sh
- Apr 15, 26option exerciseLe Goff Corinne · Chief Commercial Officer39,344 sh
- Apr 15, 26option exerciseLe Goff Corinne · Chief Commercial Officer3,644 sh
🐶 Hiring Signal
next earnings Nov 5, 2026
News
no news has mentioned this company yet
Data sources
last refreshed 19m ago
Found something off?
comments(0)
5-min edit window · permanent after that